Atorvastatin : A potent new HMG-CoA reductase inhibitorHILLEMAN, D. E; SEYEDROUBARI, A.Cardiovascular reviews & reports. 1998, Vol 19, Num 5, pp 32-48, issn 0197-3118, 9 p.Article

Dofetilide, a new class III antiarrhythmic agentLENZ, T. L; HILLEMAN, D. E.Pharmacotherapy. 2000, Vol 20, Num 7, pp 776-786, issn 0277-0008Article

Substituting nifedipine-gits for immediate-release calcium-channel antagonists in patients with stable angina pectorisMOHIUDDIN, S. M; HILLEMAN, D. E.Current therapeutic research. 1991, Vol 50, Num 4, pp 546-552, issn 0011-393XArticle

Gender and racial bias in clinical pharmacology trialsMOHIUDDIN, S. M; HILLEMAN, D. E.The Annals of pharmacotherapy. 1993, Vol 27, Num 7-8, pp 972-973, issn 1060-0280Article

Management of peripheral arterial diseaseHILLEMAN, D. E.American journal of health-system pharmacy. 1998, Vol 55, Num 19, pp S21-S27, issn 1079-2082, SUP1Conference Paper

Role of milrinone in the management of congestive heart failureHILLEMAN, D. E; FORBES, W. P.DICP (Cincinnati, Ohio). 1989, Vol 23, Num 5, pp 357-362, issn 1042-9611Article

Pharmacoeconomic assessment of HMG-CoA reductase inhibitor therapy : An analysis based on the CURVES studyHILLEMAN, D. E; HEINEMAN, S. M; FORAL, P. A et al.Pharmacotherapy. 2000, Vol 20, Num 7, pp 819-822, issn 0277-0008Article

Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessationHILLEMAN, D. E; MOHIUDDIN, S. M; DELCORE, M. G et al.Journal of clinical pharmacology. 1994, Vol 34, Num 3, pp 222-224, issn 0091-2700Article

Assessing the treatment of congestive heart failure : inotropic agents and calcium channel blockersHILLEMAN, D. E.Pharmacotherapy. 1993, Vol 13, Num 5, pp 88S-93S, issn 0277-0008, 2Conference Paper

Adverse reactions during acute and chronic class I antiarrhythmic therapyHILLEMAN, D. E; SYED M. MOHIUDDIN; GANNON, J. M et al.Current therapeutic research. 1992, Vol 51, Num 5, pp 730-738, issn 0011-393XArticle

Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertensionHILLEMAN, D. E; REYES, A. P; WURDEMAN, R. L et al.Journal of human hypertension. 2001, Vol 15, Num 8, pp 559-565, issn 0950-9240Article

Advances in the treatment of congestive heart failure : New approaches for an old diseaseSKRABAL, M. Z; STADING, J. A; BEHMER-MILLER, K. A et al.Pharmacotherapy. 2000, Vol 20, Num 7, pp 787-804, issn 0277-0008Article

Restenosis, the Achilles' heel of coronary angioplastyWURDEMAN, R. L; HILLEMAN, D. E; MOOSS, A. N et al.Pharmacotherapy. 1998, Vol 18, Num 5, pp 1024-1040, issn 0277-0008Conference Paper

Loss of efficacy during long-term cifenline therapy : development of antiarrhythmic resistance ?MOHIUDDIN, S. M; HEE, T. T; HUNTER, C. B et al.The Annals of pharmacotherapy. 1993, Vol 27, Num 5, pp 550-554, issn 1060-0280Article

Myocardial uptake and clearance of T1-201 in healthy subjects: comparison of adenosine-induced hyperemia and exercise stressSIFFRING, P. A; GUPTA, N. C; MOHIUDDIN, S. M et al.Radiology. 1989, Vol 173, Num 3, pp 769-774, issn 0033-8419, 6 p.Conference Paper

Tocainide kinetics in congestive heart failureMOHIUDDIN, S. M; ESTERBROOKS, D; HILLEMAN, D. E et al.Clinical pharmacology and therapeutics. 1983, Vol 34, Num 5, pp 596-603, issn 0009-9236Article

Time to treatment and cost of thrombolysis : A multicenter comparison of tPA and rPASEYEDROUDBARI, A; KESSLER, E. R; MOOSS, A. N et al.Journal of thrombosis and thrombolysis. 2000, Vol 9, Num 3, pp 303-308, issn 0929-5305Article

Further elucidation of pharmacokinetic interaction between diltiazem and warfarinSTOYSICH, A. M; LUCAS, B. D; MOHIUDDIN, S. M et al.International journal of clinical pharmacology and therapeutics. 1996, Vol 34, Num 2, pp 56-60, issn 0946-1965Article

Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertensionHILLEMAN, D. E; MOHIUDDIN, S. M; LUCAS, B. D et al.Clinical therapeutics. 1994, Vol 16, Num 1, pp 88-102, issn 0149-2918Article

Effects of verapamil on postextrasystolic potentiationMOOSS, A. N; HILLEMAN, D. E; RYSAVY, J et al.Chest. 1992, Vol 101, Num 5, pp 1438-1441, issn 0012-3692Article

Impact of chronic oral H₂-antagonist therapy on left ventricular systolic function and exercise capacityHILLEMAN, D. E; MOHIUDDIN, S. M; WILLIAMS, M. A et al.Journal of clinical pharmacology. 1992, Vol 32, Num 11, pp 1033-1037, issn 0091-2700Article

Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardiaMOOSS, A. N; MOHIUDDIN, S. M; HEE, T. T et al.The American journal of cardiology. 1990, Vol 65, Num 9, pp 609-614, issn 0002-9149Article

Myocardial infarction after dipyridamole-assisted thallium-201 imagingBIDDLE, P; LANSPA, T. J; MOHIUDDIN, S. M et al.DICP (Cincinnati, Ohio). 1989, Vol 23, Num 9, pp 665-667, issn 1042-9611Article

A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemiaHILLEMAN, D. E; PHILLIPS, J. O; MOHIUDDIN, S. M et al.Clinical therapeutics. 1999, Vol 21, Num 3, pp 536-562, issn 0149-2918Article

Outcomes and costs of positron emission tomography: Comparison of intravenous adenosine and intravenous dipyridamoleHOLMBERG, M. J; MOHIUDDIN, S. M; HILLEMAN, D. E et al.Clinical therapeutics. 1997, Vol 19, Num 3, pp 570-581, issn 0149-2918Article